MAPT and Alzheimer disease: In a clinical study, two major brain glucose transporters, GLUT1 and GLUT3, responsible for glucose uptake into neurons, were decreased in AD brains; notably, this decrease correlated to the hyperphosphorylation of tau and downregulation of HIF-1α, but not HIF-1β [110].